Many service provision contracts have been signed with the Montpellier scientific platform
- Montpellier Inserm U 583 :
Study of the impact of 7β-hydroxycholesterol on intracellular mechanism and raft dynamics
- ENSCM :
Chemical synthesis of our antiglioblastoma compounds.
- CHRU :
Study of the impact of our BI-1 compound on lymphocyte functionality; Study of the impact of our BI-1 compound on NKT cells; Molecular study of imbalances of the MHC1 complex in patients presenting an acquired immuno-deficiency syndrome. Study of the protective effect of our BI-1 compound on immune system cells before cryo-freezing.